Cumulative burden of oral corticosteroid adverse effects and the economic implications of corticosteroid use in patients with systemic lupus erythematosus.

@article{Shah2013CumulativeBO,
  title={Cumulative burden of oral corticosteroid adverse effects and the economic implications of corticosteroid use in patients with systemic lupus erythematosus.},
  author={Manan B Shah and Sham L Chaudhari and Trent P McLaughlin and Hong J. Kan and Benno Bechtel and Gregory J Dennis and Charles T. Molta},
  journal={Clinical therapeutics},
  year={2013},
  volume={35 4},
  pages={486-97}
}
BACKGROUND Corticosteroids (CSs) are used to treat patients with systemic lupus erythematosus (SLE) and are associated with potential adverse events (AEs). However, few data are currently available on the risk of AEs in CS users in an SLE population. OBJECTIVE To examine AEs related to CS use and costs of treating CS-related AEs in patients with SLE. METHODS In a retrospective cohort study using claims data (study period: January 1, 2000-June 30, 2010), patients aged ≥18 years having ≥2 SLE… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

Similar Papers

Loading similar papers…